Crisaborole Ointment 2% Skin Biomarker Biopsy Study in Atopic Dermatitis

A Phase 2a, Randomized, Double-Blind, Vehicle-Controlled Study, to Characterize the Mechanism of Action of
Crisaborole Ointment 2%, by Evaluation of Efficacy and Changes in Skin Biomarkers, in Adult Subjects With Mild to Moderate Atopic Dermatitis, With a 4 Week Open-Label Extension

Category & Conditions:
Skin Diseases and Conditions
Medicine:
EUCRISA™(CRISABOROLE)
ClinicalTrials.gov Identifier (NCT):
Protocol ID:
C3291001
Open Plain Language Summary Result:Click here